Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Employer-incurred health care costs and productivity losses associated with influenza</title><author><name sortKey="Karve, Sudeep" sort="Karve, Sudeep" uniqKey="Karve S" first="Sudeep" last="Karve">Sudeep Karve</name><affiliation><nlm:aff id="A1">RTI Health Solutions; Research Triangle Park, NC USA</nlm:aff></affiliation></author><author><name sortKey="Misurski, Derek A" sort="Misurski, Derek A" uniqKey="Misurski D" first="Derek A." last="Misurski">Derek A. Misurski</name><affiliation><nlm:aff id="A2">GlaxoSmithKline; Philadelphia, PA USA</nlm:aff></affiliation></author><author><name sortKey="Meier, Genevieve" sort="Meier, Genevieve" uniqKey="Meier G" first="Genevieve" last="Meier">Genevieve Meier</name><affiliation><nlm:aff id="A2">GlaxoSmithKline; Philadelphia, PA USA</nlm:aff></affiliation></author><author><name sortKey="Davis, Keith L" sort="Davis, Keith L" uniqKey="Davis K" first="Keith L." last="Davis">Keith L. Davis</name><affiliation><nlm:aff id="A1">RTI Health Solutions; Research Triangle Park, NC USA</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">23321849</idno><idno type="pmc">3903904</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903904</idno><idno type="RBID">PMC:3903904</idno><idno type="doi">10.4161/hv.23413</idno><date when="2013">2013</date><idno type="wicri:Area/Pmc/Corpus">000695</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000695</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Employer-incurred health care costs and productivity losses associated with influenza</title><author><name sortKey="Karve, Sudeep" sort="Karve, Sudeep" uniqKey="Karve S" first="Sudeep" last="Karve">Sudeep Karve</name><affiliation><nlm:aff id="A1">RTI Health Solutions; Research Triangle Park, NC USA</nlm:aff></affiliation></author><author><name sortKey="Misurski, Derek A" sort="Misurski, Derek A" uniqKey="Misurski D" first="Derek A." last="Misurski">Derek A. Misurski</name><affiliation><nlm:aff id="A2">GlaxoSmithKline; Philadelphia, PA USA</nlm:aff></affiliation></author><author><name sortKey="Meier, Genevieve" sort="Meier, Genevieve" uniqKey="Meier G" first="Genevieve" last="Meier">Genevieve Meier</name><affiliation><nlm:aff id="A2">GlaxoSmithKline; Philadelphia, PA USA</nlm:aff></affiliation></author><author><name sortKey="Davis, Keith L" sort="Davis, Keith L" uniqKey="Davis K" first="Keith L." last="Davis">Keith L. Davis</name><affiliation><nlm:aff id="A1">RTI Health Solutions; Research Triangle Park, NC USA</nlm:aff></affiliation></author></analytic><series><title level="j">Human Vaccines & Immunotherapeutics</title><idno type="ISSN">2164-5515</idno><idno type="eISSN">2164-554X</idno><imprint><date when="2013">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>The primary objective of this study was to assess trends in employer expenditures for both direct medical costs and indirect productivity losses associated with influenza. A retrospective analysis was performed using two of the MarketScan family of databases for 2005–2009. Patients with at least one diagnosis claim for influenza during an influenza season were selected. We estimated seasonal incidence of influenza in the employed population from the MarketScan Commercial Claims and Encounters database. Health care utilization and costs and productivity losses were assessed during the 21-d period following the influenza diagnosis date. Compared with the 2005–2006 season (493 per 100,000 plan members), influenza incidence increased during the 2006–2007 (598 per 100,000 plan members) and 2007–2008 (1,142 per 100,000 plan members) seasons and had a dramatic increase during the pandemic season of 2008–2009 (1,715 per 100,000 plan members) . The total influenza-related employer spending per 100,000 plan members also increased by over 400% during the 2008–2009 influenza season [$623,248; confidence interval (CI]):$601,518-$644,991], compared with 2005–2006 ($145,834; 95% CI: $135,067-$156,603). The primary drivers of the increased costs were emergency room, outpatient and inpatient visits. Total costs associated with influenza-related missed work time per 100,000 plan members increased over 4-fold from $26,479 in the 2005–2006 influenza season to $122,811 in 2008–2009. Overall, as expected, considerably higher direct and indirect costs were observed during the 2008–2009 influenza pandemic season than during other influenza seasons. In recent years, the influenza-related employer burden has increased considerably. In future, employers may need efficient resource allocation in order to address the productivity losses and increasing direct medical costs associated with increased influenza incidence. One of the strategies that employers may consider is increasing influenza vaccination rates among employees, which likely will help lower the influenza incidence and the associated downstream direct and indirect costs.</p></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Hum Vaccin Immunother</journal-id><journal-id journal-id-type="iso-abbrev">Hum Vaccin Immunother</journal-id><journal-id journal-id-type="publisher-id">HV</journal-id><journal-title-group><journal-title>Human Vaccines & Immunotherapeutics</journal-title></journal-title-group><issn pub-type="ppub">2164-5515</issn><issn pub-type="epub">2164-554X</issn><publisher><publisher-name>Landes Bioscience</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23321849</article-id><article-id pub-id-type="pmc">3903904</article-id><article-id pub-id-type="publisher-id">2012HV0298R</article-id><article-id pub-id-type="doi">10.4161/hv.23413</article-id><article-id pub-id-type="pii">23413</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Paper</subject></subj-group></article-categories><title-group><article-title>Employer-incurred health care costs and productivity losses associated with influenza</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Karve</surname><given-names>Sudeep</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Misurski</surname><given-names>Derek A.</given-names></name><xref ref-type="aff" rid="A2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Meier</surname><given-names>Genevieve</given-names></name><xref ref-type="aff" rid="A2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Davis</surname><given-names>Keith L.</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref></contrib><aff id="A1"><label>1</label>RTI Health Solutions; Research Triangle Park, NC USA</aff><aff id="A2"><label>2</label>GlaxoSmithKline; Philadelphia, PA USA</aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Correspondence to: Sudeep Karve, Email: <email xlink:href="sjkarve@rti.org">sjkarve@rti.org</email></corresp></author-notes><pub-date pub-type="ppub"><day>01</day><month>4</month><year>2013</year></pub-date><pub-date pub-type="epub"><day>15</day><month>1</month><year>2013</year></pub-date><volume>9</volume><issue>4</issue><fpage>841</fpage><lpage>857</lpage><history><date date-type="received"><day>24</day><month>9</month><year>2012</year></date><date date-type="rev-recd"><day>15</day><month>12</month><year>2012</year></date><date date-type="accepted"><day>25</day><month>12</month><year>2012</year></date></history><permissions><copyright-statement>Copyright © 2013 Landes Bioscience</copyright-statement><copyright-year>2013</copyright-year></permissions><abstract><p>The primary objective of this study was to assess trends in employer expenditures for both direct medical costs and indirect productivity losses associated with influenza. A retrospective analysis was performed using two of the MarketScan family of databases for 2005–2009. Patients with at least one diagnosis claim for influenza during an influenza season were selected. We estimated seasonal incidence of influenza in the employed population from the MarketScan Commercial Claims and Encounters database. Health care utilization and costs and productivity losses were assessed during the 21-d period following the influenza diagnosis date. Compared with the 2005–2006 season (493 per 100,000 plan members), influenza incidence increased during the 2006–2007 (598 per 100,000 plan members) and 2007–2008 (1,142 per 100,000 plan members) seasons and had a dramatic increase during the pandemic season of 2008–2009 (1,715 per 100,000 plan members) . The total influenza-related employer spending per 100,000 plan members also increased by over 400% during the 2008–2009 influenza season [$623,248; confidence interval (CI]):$601,518-$644,991], compared with 2005–2006 ($145,834; 95% CI: $135,067-$156,603). The primary drivers of the increased costs were emergency room, outpatient and inpatient visits. Total costs associated with influenza-related missed work time per 100,000 plan members increased over 4-fold from $26,479 in the 2005–2006 influenza season to $122,811 in 2008–2009. Overall, as expected, considerably higher direct and indirect costs were observed during the 2008–2009 influenza pandemic season than during other influenza seasons. In recent years, the influenza-related employer burden has increased considerably. In future, employers may need efficient resource allocation in order to address the productivity losses and increasing direct medical costs associated with increased influenza incidence. One of the strategies that employers may consider is increasing influenza vaccination rates among employees, which likely will help lower the influenza incidence and the associated downstream direct and indirect costs.</p></abstract><kwd-group kwd-group-type="author"><title>Keywords: </title><kwd>employer burden</kwd><kwd>influenza</kwd><kwd>health care cost</kwd><kwd>productivity</kwd></kwd-group></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 0006959 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 0006959 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé=
|texte=
}}
| This area was generated with Dilib version V0.6.34. |  |